Phillips AN - Search Results

1

Virological rebound after suppression on highly active antiretroviral therapy.

Mocroft A, Ruiz L, Reiss P, Ledergerber B, Katlama C, Lazzarin A, Goebel FD, Phillips AN, Clotet B, Lundgren JD; EuroSIDA study group. Mocroft A, et al. Among authors: phillips an. AIDS. 2003 Aug 15;17(12):1741-51. doi: 10.1097/00002030-200308150-00003. AIDS. 2003. PMID: 12891060

2

Prediction of progression to AIDS by analysis of CD4 lymphocyte counts in a haemophilic cohort.

Phillips A, Lee CA, Elford J, Janossy G, Bofill M, Timms A, Kernoff PB. Phillips A, et al. AIDS. 1989 Nov;3(11):737-41. doi: 10.1097/00002030-198911000-00008. AIDS. 1989. PMID: 2575912

3

CD8+,CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patients.

Mocroft A, Bofill M, Lipman M, Medina E, Borthwick N, Timms A, Batista L, Winter M, Sabin CA, Johnson M, Lee CA, Phillips A, Janossy G. Mocroft A, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Feb 1;14(2):158-62. doi: 10.1097/00042560-199702010-00009. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9052725

4

Access to medical care one year prior to diagnosis in 100 HIV-positive women.

Madge S, Olaitan A, Mocroft A, Phillips A, Johnson M. Madge S, et al. Fam Pract. 1997 Jun;14(3):255-7. doi: 10.1093/fampra/14.3.255. Fam Pract. 1997. PMID: 9201502

5

Virological response to protease inhibitor therapy in an HIV clinic cohort.

Staszewski S, Miller V, Sabin C, Carlebach A, Berger AM, Weidmann E, Helm EB, Hill A, Phillips A. Staszewski S, et al. AIDS. 1999 Feb 25;13(3):367-73. doi: 10.1097/00002030-199902250-00009. AIDS. 1999. PMID: 10199227

6

Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy.

Staszewski S, Miller V, Sabin C, Schlecht C, Gute P, Stamm S, Leder T, Berger A, Weidemann E, Hill A, Phillips A. Staszewski S, et al. AIDS. 1999 May 28;13(8):951-6. doi: 10.1097/00002030-199905280-00011. AIDS. 1999. PMID: 10371176

7

Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure.

Miller V, Sabin C, Hertogs K, Bloor S, Martinez-Picado J, D'Aquila R, Larder B, Lutz T, Gute P, Weidmann E, Rabenau H, Phillips A, Staszewski S. Miller V, et al. AIDS. 2000 Dec 22;14(18):2857-67. doi: 10.1097/00002030-200012220-00007. AIDS. 2000. PMID: 11153667

8

Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy.

Martínez E, Blanco JL, Arnaiz JA, Pérez-Cuevas JB, Mocroft A, Cruceta A, Marcos MA, Milinkovic A, García-Viejo MA, Mallolas J, Carné X, Phillips A, Gatell JM. Martínez E, et al. AIDS. 2001 Jul 6;15(10):1261-8. doi: 10.1097/00002030-200107060-00007. AIDS. 2001. PMID: 11426070

9

Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study.

Martinez E, Mocroft A, García-Viejo MA, Pérez-Cuevas JB, Blanco JL, Mallolas J, Bianchi L, Conget I, Blanch J, Phillips A, Gatell JM. Martinez E, et al. Lancet. 2001 Feb 24;357(9256):592-8. doi: 10.1016/S0140-6736(00)04056-3. Lancet. 2001. PMID: 11558485

10

Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study.

Matthews GV, Sabin CA, Mandalia S, Lampe F, Phillips AN, Nelson MR, Bower M, Johnson MA, Gazzard BG. Matthews GV, et al. Among authors: phillips an. AIDS. 2002 Jan 4;16(1):53-61. doi: 10.1097/00002030-200201040-00008. AIDS. 2002. PMID: 11741163 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

522 results

Search Page